Condition: Acute Coronary Syndromes · Coronary Arterial Disease (CAD) · Inflammation · Sponsor: Abcentra
The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarction who have elevated coronary inflammation based on CCTA. The main question it aims to answer is: Clinical effects of orticumab treatment on inflammation of the coronary artery parameters measured with CCTA Researchers will compare the effects with placebo group after 6 months of treatment Participants will Keep the planned study visit appointments Provide complete information about medical and medical history Speak to the study doctor before changing any of non-study treatments, including starting new medications, receiving any vaccinations, or setting out to join any other clinical studies
This description comes directly from the study's public registry record.
Abcentra · 424-369-4401 · info@abcentra.com
Always discuss trial participation with your own doctor first.
| Abcentra Investigational Site | Los Angeles, California, United States | Not Yet Recruiting |
| Abcentra Investigational Site | Torrance, California, United States | Recruiting |
| Abcentra Investigational Site | Boca Raton, Florida, United States | Recruiting |
| Abcentra Investigational Site | Richmond, Indiana, United States | Recruiting |
| Abcentra Investigational Site | Louisville, Kentucky, United States | Not Yet Recruiting |
| Abcentra Investigational Site | Baltimore, Maryland, United States | Recruiting |
| Abcentra Investigational Site | Midland, Michigan, United States | Recruiting |
| Abcentra Investigational Site | Ostrava, Moravian-Silesian Region, Czechia | Recruiting |
| Abcentra Investigational Site | Pilsen, Plzeň Region, Czechia | Recruiting |
| Abcentra Investigational Site | Prague, Praha 2, Czechia | Recruiting |
| Abcentra Investigational Site | Prague, Praha 4, Czechia | Recruiting |
| Abcentra Investigational Site | Brno, South Moravian, Czechia | Recruiting |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06927739